Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (AU:NXS)
ASX:NXS
Holding AU:NXS?
Track your performance easily
NXS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.12 - AU$0.50
Previous CloseAU$0.14
Volume26.08K
Average Volume (3M)206.70K
Market Cap
AU$40.90M
Enterprise ValueAU$34.95M
Total Cash (Recent Filing)$5.11M
Total Debt (Recent Filing)$1.22M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Feb 26, 2025EPS Estimate
-AU$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares OutstandingN/A
10 Day Avg. Volume287,541
30 Day Avg. Volume206,702
Standard Deviation0.19
R-Squared0.26
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)8.67
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.82
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.40Price Target Upside185.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Next Science Ltd News
PremiumCompany Announcements
Next Science Ltd’s XPERIENCE Shows Zero Infection RatePremiumCompany Announcements
Next Science Ltd: Innovations in Healthcare Market
PremiumCompany Announcements
Next Science Director’s Stake Surges Post-AGM
PremiumCompany Announcements
Next Science Limited Expands Unquoted Equity
PremiumCompany Announcements
Next Science Revolutionizes Surgical Care Market
PremiumCompany Announcements
Next Science Records Revenue and Profit Surge
PremiumCompany Announcements
Next Science’s Revenue Up, Losses Down in H1 2024
PremiumCompany Announcements
Next Science Withdraws FY24 Guidance Amid Sales RevampOptions Prices
Currently, No data available
---
Ownership Overview
0.23% Insiders
<0.01% Other Institutional Investors
99.77% Public Companies and
Individual Investors
NXS FAQ
What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest share price was AU$0.12 and its highest was AU$0.50 in the past 12 months.
What is Next Science Ltd’s market cap?
Currently, no data Available
When is Next Science Ltd’s upcoming earnings report date?
Next Science Ltd’s upcoming earnings report date is Feb 26, 2025 which is in 96 days.
How were Next Science Ltd’s earnings last quarter?
Next Science Ltd released its earnings results on Aug 29, 2024. The company reported -AU$0.031 earnings per share for the quarter, missing the consensus estimate of -AU$0.029 by -AU$0.002.
Is Next Science Ltd overvalued?
According to Wall Street analysts Next Science Ltd’s price is currently Undervalued.
Does Next Science Ltd pay dividends?
Next Science Ltd does not currently pay dividends.
What is Next Science Ltd’s EPS estimate?
Next Science Ltd’s EPS estimate is -AU$0.03.
How many shares outstanding does Next Science Ltd have?
Next Science Ltd has 292,160,250 shares outstanding.
What happened to Next Science Ltd’s price movement after its last earnings report?
Next Science Ltd reported an EPS of -AU$0.031 in its last earnings report, missing expectations of -AU$0.029. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of Next Science Ltd?
Currently, no hedge funds are holding shares in AU:NXS
---
Next Science Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.40 (185.11% Upside)
AU$0.40 (185.11% Upside)
Blogger Sentiment
Bullish
AU:NXS Sentiment 90%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.67%
12-Months-Change
Fundamentals
Return on Equity
-382.93%
Trailing 12-Months
Asset Growth
-0.51%
Trailing 12-Months
Company Description
Next Science Ltd
Next Science Ltd is an Australia based company formed to commercialise and develop its Xbio technology, which is a non-toxic technology with efficacy in eradicating both biofilm based and free-floating bacteria. The company's products includes SurgX Sterile wound Gel, Bactisure Surgical Lavage and Blast X Wound Gel.
---
NXS Stock 12 Month Forecast
Average Price Target
AU$0.40
▲(185.11% Upside)
Technical Analysis
Aptevo Therapeutics
―
BioNano Genomics
―
Helius Medical Technologies
―
Advaxis
―
Next Science Ltd
―
Best Analysts Covering NXS
1 Year
1 Year Success Rate
0/11 ratings generated profit
1 Year Average Return
-51.25%
reiterated a buy rating 30 days ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -51.25% per trade.
---